Cardiovascular Disease Doctors in Arecibo, PR Accepting Medicare

7 Cardiovascular Disease doctors found. Showing 1 - 7

Francisco Garcia-cortes, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 47 Calle Morell Campos, Arecibo, PR 00612 Phone: 787-878-9300    Fax: 787-879-3372

Juan C Peraza Delgado, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 258 Calle Ventura Gandarilla, Arecibo, PR 00612 Phone: 787-878-4150

Dr. Jose David Rivera, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 19 Ave Jose De Diego, Arecibo, PR 00612 Phone: 787-880-2200    Fax: 787-878-0532

Rafael Delgado Cruz, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Ave Rafael Rivera Aulet 320, Arecibo, PR 00612 Phone: 787-878-2267    Fax: 787-878-2260

Joseph Manuel Maldonado, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 158 Calle Delfin Olmo, Arecibo, PR 00612 Phone: 787-817-0763    Fax: 787-879-8671

Mr. Manuel Z Rivera, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Ofic 211 Arecibo Medical Center, Arecibo, PR 00612 Phone: 787-878-3107    Fax: 787-880-4265

Luis M. Rodriguez-mora, M.D. Internal Medicine - Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 55 Calle Palma, Susoni Medical Building, Suite 101, Arecibo, PR 00612 Phone: 787-878-4800    Fax: 787-817-1237

News Archive

YM BioSciences' CYT387 receives European Commission positive opinion for Orphan Drug Designation

YM BioSciences Inc., today announced that it has received positive opinions from the Committee for Orphan Medicinal Products of the European Commission to grant Orphan Medicinal Product Designation to its JAK1/JAK2 inhibitor, CYT387, for the treatment of primary myelofibrosis, post-polycythaemia vera myelofibrosis and post-essential thrombocythaemia myelofibrosis.

Researchers identify lymphatic endothelial lineage that shows potential for new anti-cancer treatment

Identifying the cell of origin is crucial to understanding how a tumor develops and metastasizes and for developing targeted therapies.

Study: Unusually frequent hospital visit can help spot people at risk of myeloma

A condition that can progress to myeloma could be identified in patients by their unusually frequent hospital visits, according to research presented at the 2019 NCRI Cancer Conference.

How the human brain can learn without thinking

Watch out - you may learn something and not even know it, says Takeo Watanabe, an associate professor of psychology at Boston University's Center for Brain and Memory. Watanabe and his team recently pinpointed the mechanism that makes subliminal learning work. Watanabe will present the team's findings at the American Psychological Society meeting in Los Angeles, May 27 and 28.

Read more Medical News

› Verified 3 days ago